Compare
Haemonetics vs West Pharmaceutical Services (HAE vs WST)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Haemonetics (HAE) returned +136.5% and West Pharmaceutical Services (WST) +41.0%; so far this year the figures are +49.6% and +45.3%.
West Pharmaceutical Services is the larger company by market value, about 5.1 times the size of Haemonetics.
On trailing earnings, HAE trades at 53.1 times and WST at 44.9 times.
Revenue grew +4.1% at HAE and +12.6% at WST over the last year.
HAE pays no dividend. WST yields 0.22%.
Data as of the latest close. Not investment advice.
Relative performance
| HAE | WST | |
|---|---|---|
| Price | $119.93 | $399.81 |
| 1-day | -3.37% | +1.87% |
| YTD | +49.63% | +45.31% |
| 1 year | +136.46% | +41.01% |
| 3 years | +38.82% | +24.29% |
| Market cap | $5.5B | $27.9B |
| P/E | 53.1 | 44.9 |
| P/S | 3.95 | 8.20 |
| P/B | 6.08 | 9.38 |
| Revenue growth | +4.10% | +12.60% |
| EPS growth | -33.90% | +32.00% |
| Gross margin % | 59.6 | 37.6 |
| Net margin % | 7.5 | 18.8 |
| ROE % | 11.6 | 21.5 |
| Debt / equity | 1.25 | 0.07 |
| FCF yield % | 5.5 | 1.6 |
| Dividend yield % | — | 0.22 |
| Beta | 0.14 | 0.66 |
| RSI (14) | 55.5 | 57.5 |
| Technical rating |